237 results on '"C. Derosa"'
Search Results
2. Aptamer based Lateral Flow Assays for Rapid and Sensitive Detection of CKD marker Cystatin C.
- Author
-
Satheesh Natarajan, Maria C. DeRosa, Jayaraj Joseph, Malay Ilesh Shah, and Srinivasa Karthik
- Published
- 2021
- Full Text
- View/download PDF
3. Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
- Author
-
Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan, Mark Wunderlich, Bahareh Hosseinpour, Bianca S. Bono, Melissa J. Chee, James C. Mulloy, William G. Willmore, Maria C. DeRosa, and Edward J. Merino
- Subjects
Medicine ,Science - Abstract
Abstract Current classes of cancer therapeutics have negative side effects stemming from off-target cytotoxicity. One way to avoid this would be to use a drug delivery system decorated with targeting moieties, such as an aptamer, if a targeted aptamer is available. In this study, aptamers were selected against acute myeloid leukemia (AML) cells expressing the MLL-AF9 oncogene through systematic evolution of ligands by exponential enrichment (SELEX). Twelve rounds of SELEX, including two counter selections against fibroblast cells, were completed. Aptamer pools were sequenced, and three candidate sequences were identified. These sequences consisted of two 23-base primer regions flanking a 30-base central domain. Binding studies were performed using flow cytometry, and the lead sequence had a binding constant of 37.5 + / − 2.5 nM to AML cells, while displaying no binding to fibroblast or umbilical cord blood cells at 200 nM. A truncation study of the lead sequence was done using nine shortened sequences, and showed the 5′ primer was not important for binding. The lead sequence was tested against seven AML patient cultures, and five cultures showed binding at 200 nM. In summary, a DNA aptamer specific to AML cells was developed and characterized for future drug-aptamer conjugates.
- Published
- 2021
- Full Text
- View/download PDF
4. Polymer Brush–GaAs Interface and Its Use as an Antibody-Compatible Platform for Biosensing
- Author
-
Daniela T. Marquez, Juliana Chawich, Walid M. Hassen, Khalid Moumanis, Maria C. DeRosa, and Jan J. Dubowski
- Subjects
Chemistry ,QD1-999 - Published
- 2021
- Full Text
- View/download PDF
5. Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents
- Author
-
Anna Koudrina and Maria C. DeRosa
- Subjects
Chemistry ,QD1-999 - Published
- 2020
- Full Text
- View/download PDF
6. Development of a Health Equity Integration Dashboard (HEID) using Race Ethnicity and Language (REaL) Data in a Pediatric Hospital Setting: Lessons Learned in Visual Strategies and Key Data Elements.
- Author
-
Raquel G. Hernandez, Paola B. Dees, Joann C. Derosa, Fiorella Gonzalez, Christine Hammerschmidt, John Morrison, Benton Ng, Ashish B. Shah, and Luis M. Ahumada
- Published
- 2021
7. Envisioning the scientific paper of the future
- Author
-
Natalie M. Sopinka, Laura E. Coristine, Maria C. DeRosa, Chelsea M. Rochman, Brian L. Owens, and Steven J. Cooke
- Subjects
science communication ,open science ,scholarly publishing ,peer review ,science writing ,Education ,Science - Abstract
Consider for a moment the rate of advancement in the scientific understanding of DNA. It is formidable; from Fredrich Miescher’s nuclein extraction in the 1860s to Rosalind Franklin’s double helix X-ray in the 1950s to revolutionary next-generation sequencing in the late 2000s. Now consider the scientific paper, the medium used to describe and publish these advances. How is the scientific paper advancing to meet the needs of those who generate and use scientific information? We review four essential qualities for the scientific paper of the future: (i) a robust source of trustworthy information that remains peer reviewed and is (ii) communicated to diverse users in diverse ways, (iii) open access, and (iv) has a measurable impact beyond Impact Factor. Since its inception, scientific literature has proliferated. We discuss the continuation and expansion of practices already in place including: freely accessible data and analytical code, living research and reviews, changes to peer review to improve representation of under-represented groups, plain language summaries, preprint servers, evidence-informed decision-making, and altmetrics.
- Published
- 2020
- Full Text
- View/download PDF
8. Soil invertebrate toxicity and bioaccumulation of nano copper oxide and copper sulphate in soils, with and without biosolids amendment
- Author
-
Jessica R. Velicogna, Dina Schwertfeger, Alexander Jesmer, Claudia Beer, Joner Kuo, Maria C. DeRosa, Rick Scroggins, Myron Smith, and Juliska Princz
- Subjects
Nanomaterials ,Nano-copper ,Soil invertebrates ,Toxicity ,Bioaccumulation ,Bioavailability ,Environmental pollution ,TD172-193.5 ,Environmental sciences ,GE1-350 - Abstract
The fate, toxicity and bioaccumulation of copper oxide nanoparticles (nCuO) was investigated in soil, with and without biosolids amendment, through chronic exposures using the earthworm, Eisenia andrei, and the collembolan, Folsomia candida. The effects of copper sulphate (CuSO4) were included so as to compare the behavior of nCuO to a readily soluble counterpart. The fate of nCuO was evaluated through characterization of dissolved and nano-particulate fractions (via single particle ICP-MS) as well as extractable Cu2+ throughout the duration of select tests. Neither Cu form was particularly toxic to F. candida, but effects on E. andrei reproduction were significant in all treatments (IC50 range: 98 – 149 mg Cu kg−1 dry soil). There were no significant differences in toxicity between the Cu forms, nor in extractable Cu2+ activities, indicative that particle dissolution within the soil and, subsequent activity of Cu2+ was likely the primary mode of toxicity in the nCuO exposures. The presence of biosolids did not significantly alter toxicity of nCuO, but did affect Cu2+ activity over time. Bioaccumulation of total Cu in E. andrei when exposed to nCuO (kinetic bioaccumulation factor (BAFk): 0.80 with biosolids and 0.81 without) was lower than exposure to CuSO4 (BAFk: 2.31 with biosolids and 1.12 without). Enhanced dark-field hyperspectral imaging showed accumulation of nCuO along the epidermis and gut of E. andrei, with trace amounts observed in muscle and chloragogenous tissue, providing evidence of nCuO translocation within the organism. The present study demonstrates that the current risk assessment approach for trace metals in the environment, based on substance solubility and bioavailability of the dissolved free ion, are applicable for nCuO exposure to soil invertebrates, but that the rate of particle dissolution in different soil environments is an important factor for consideration.
- Published
- 2021
- Full Text
- View/download PDF
9. Optimized experimental pre-treatment strategy for temporary inhibition of islet amyloid polypeptide aggregation
- Author
-
Madison Q. Ferguson and Maria C. DeRosa
- Subjects
Islet amyloid polypeptide ,Aggregation ,Fibril ,Type 1 diabetes ,Type 2 diabetes ,Thioflavin T assay ,Biology (General) ,QH301-705.5 ,Biochemistry ,QD415-436 - Abstract
Islet amyloid polypeptide (IAPP) is a neuroendocrine hormone from pancreatic β-cells. Misfolded, aggregated IAPP is believed to be toxic to islet cells and amyloid deposits in the pancreas are pathological hallmarks of type 2 diabetes. Rapid fibrillization of this peptide makes it difficult to study in its soluble form, impeding a better understanding of its role. In this study, a variety of popular pretreatment methods were tested for their ability to delay aggregation of IAPP, including solutions of hexafluoroisopropanol, sodium hydroxide, hydrochloric acid, phosphate buffered saline, ammonium hydroxide, as well as tris buffer at different pH and containing either calcium (II), zinc (II), or iron (II). Aggregation was assessed using the thioflavin T fluorescence assay as well as by transmission electron microscopy. Tris buffer at pH 8.1 containing Zn(II) was found to have the best balance of temporary inhibition of aggregation and biological relevance.
- Published
- 2021
- Full Text
- View/download PDF
10. Quality Initiative Using Theory of Change and Visual Analytics to Improve Controlled Substance Documentation Discrepancies in the Operating Room.
- Author
-
Jenny E. Dolan, Hannah Lonsdale, Luis M. Ahumada, Amish Patel, Jibin Samuel, Ali Jalali, Jacquelin Peck, Joann C. Derosa, Mohamed A. Rehman, Anna M. Varughese, and Allison M. Fernandez
- Published
- 2019
- Full Text
- View/download PDF
11. Synthesis, transfer, and characterization of core-shell gold-coated magnetic nanoparticles
- Author
-
McKenzie Smith, Maureen McKeague, and Maria C. DeRosa
- Subjects
Science - Abstract
Magnetic separation has gained new popularity as a versatile partitioning method with the recent growth in nanotechnology and related biotechnology applications. In this study, iron oxide magnetic nanoparticles were synthesized via solvothermal methods and directly coated with gold to form core-shell gold-coated magnetic nanoparticles (Fe3O4-AuNPs). High-resolution transmission electron microscopy with Energy dispersive X-ray spectroscopy results suggests that temperature and reaction time play an important role in the formation of small, monodisperse Fe3O4-AuNPs. We also demonstrate that increased 4- dimethyl(amino)pyridine (DMAP) concentrations and vigorous stirring were required to successfully transfer Fe3O4-AuNPs into aqueous solution. The structure and morphology of the synthesized and transferred Fe3O4-AuNPs was further confirmed by UV–vis absorption spectroscopy and solubility experiments. • Direct coating of Fe3O4 with Au: Slowly heating by (10 °C/ min) until 180–190 °C without exceeding this reaction temperature and increasing the reaction time to 3 h from 1.5 h • High yield transfer of Fe3O4-AuNPs was achieved using 4- dimethyl(amino)pyridine (DMAP) as phase transfer catalyst Method name: Solvothermal synthesis of iron oxide nanoparticles with direct gold coating to form core-shell gold-coated magnetic nanoparticles, Phase transfer of core-shell gold-coated magnetic nanoparticles from organic to aqueous using 4-(dimethyl)amino pyridine (DMAP) as a phase transfer agent, Keywords: Iron oxide, Gold-coated, Core-shell, Core-shell gold-coated magnetic nanoparticles, Magnetic separation, Fe3O4-AuNPs, 4-Dimethyl(amino)pyridine, DMAP, Nanoparticle phase transfer, Aqueous phase transfer, Solvothermal, Thin gold coating, Nanoparticle, Synthesis
- Published
- 2019
- Full Text
- View/download PDF
12. Polymer Brushes on GaAs and GaAs/AlGaAs Nanoheterostructures: A Promising Platform for Attractive Detection of Legionella pneumophila
- Author
-
Juliana Chawich, Walid M. Hassen, Amanpreet Singh, Daniela T. Marquez, Maria C. DeRosa, and Jan J. Dubowski
- Subjects
General Chemical Engineering ,General Chemistry - Published
- 2022
- Full Text
- View/download PDF
13. Development and Evaluation of a Quantitative Fluorescent Lateral Flow Immunoassay for Cystatin-C, a Renal Dysfunction Biomarker.
- Author
-
Satheesh Natarajan, Maria C. DeRosa, Malay Ilesh Shah, and Joseph Jayaraj
- Published
- 2021
- Full Text
- View/download PDF
14. Adsorption–desorption nano-aptasensors: fluorescent screening assays for ochratoxin A
- Author
-
Velu Ranganathan, Spencer Boisjoli, and Maria C. DeRosa
- Subjects
General Chemical Engineering ,General Chemistry - Abstract
In this study, a FRET-based fluorescent aptasensor for the detection of ochratoxin A (OTA) was optimized based on the quenching efficiency of single-walled carbon nanotubes (SWCNTs) and the binding affinity of aptamers. OTA aptamers were conjugated with quantum dots and adsorbed to the surface of both acid-modified and unmodified SWCNTs. The maximum fluorescence quenching efficiency of the SWCNTs were compared. Acid-modified SWCNTs (amSWCNTs) have moderate quenching efficiency, providing an optimal sensitivity for qualitative fluorescence-enhancement biosensor assays. The binding parameters of the QD-modified OTA aptamers (1.12.2 and A08min) on the surface of amSWCNTs were compared. Based on our results, the A08min aptamer is a better candidate for OTA detection. Using the A08min aptamer, the SWCNT method had a limit of detection (LOD) of 40 nM. The amSWCNT method had a significantly lower LOD of 14 nM. Turn-on fluorescent nano-aptasensors are emerging as an effective diagnostic tool for simple detection of mycotoxins. Nanocomplexes designed for the detection of mycotoxins in solution and paper-based tests have proven to be useful.
- Published
- 2022
- Full Text
- View/download PDF
15. Microfluidics Integrated Biosensors: A Leading Technology towards Lab-on-a-Chip and Sensing Applications.
- Author
-
George Luka, Ali Ahmadi, Homayoun Najjaran, Evangelyn C. Alocilja, Maria C. DeRosa, Kirsten Wolthers, Ahmed Malki, Hassan Aziz, Asmaa Althani, and Mina Hoorfar
- Published
- 2015
- Full Text
- View/download PDF
16. Selection and Characterization of a Novel DNA Aptamer for Label-Free Fluorescence Biosensing of Ochratoxin A
- Author
-
Maureen McKeague, Ranganathan Velu, Kayla Hill, Viola Bardóczy, Tamás Mészáros, and Maria C. DeRosa
- Subjects
aptamer ,ochratoxin A ,mycotoxins ,in vitro selection ,SELEX ,SYBR Green I ,fluorescent assay ,biosensing ,aptasensor ,Medicine - Abstract
Nucleic acid aptamers are emerging as useful molecular recognition tools for food safety monitoring. However, practical and technical challenges limit the number and diversity of available aptamer probes that can be incorporated into novel sensing schemes. This work describes the selection of novel DNA aptamers that bind to the important food contaminant ochratoxin A (OTA). Following 15 rounds of in vitro selection, sequences were analyzed for OTA binding. Two of the isolated aptamers demonstrated high affinity binding and selectivity to this mycotoxin compared to similar food adulterants. These sequences, as well as a truncated aptamer (minimal sequence required for binding), were incorporated into a SYBR® Green I fluorescence-based OTA biosensing scheme. This label-free detection platform is capable of rapid, selective, and sensitive OTA quantification with a limit of detection of 9 nM and linear quantification up to 100 nM.
- Published
- 2014
- Full Text
- View/download PDF
17. Smart Materials Based on DNA Aptamers: Taking Aptasensing to the Next Level
- Author
-
Emily Mastronardi, Amanda Foster, Xueru Zhang, and Maria C. DeRosa
- Subjects
aptamers ,hydrogel ,gated nanoparticle ,nanopore ,polyelectrolyte multilayer ,Layer-by-Layer ,microcapsules ,targeted delivery ,logic gates ,Chemical technology ,TP1-1185 - Abstract
“Smart” materials are an emerging category of multifunctional materials with physical or chemical properties that can be controllably altered in response to an external stimulus. By combining the standard properties of the advanced material with the unique ability to recognize and adapt in response to a change in their environment, these materials are finding applications in areas such as sensing and drug delivery. While the majority of these materials are responsive to physical or chemical changes, a particularly exciting area of research seeks to develop smart materials that are sensitive to specific molecular or biomolecular stimuli. These systems require the integration of a molecular recognition probe specific to the target molecule of interest. The ease of synthesis and labeling, low cost, and stability of DNA aptamers make them uniquely suited to effectively serve as molecular recognition probes in novel smart material systems. This review will highlight current work in the area of aptamer-based smart materials and prospects for their future applications.
- Published
- 2014
- Full Text
- View/download PDF
18. Morphological Transformation of Silver Nanoparticles from Commercial Products: Modeling from Product Incorporation, Weathering through Use Scenarios, and Leaching into Wastewater
- Author
-
Selvan Mohan, Juliska Princz, Banu Ormeci, and Maria C. DeRosa
- Subjects
nanoparticle ,Silver (Ag) ,life cycle ,TEM ,EDS ,ICP-MS ,XPS ,Chemistry ,QD1-999 - Abstract
There is increasing interest in the environmental fate and effects of engineered nanomaterials due to their ubiquitous use in consumer products. In particular, given the mounting evidence that dramatic transformations can occur to a nanomaterial throughout its product lifecycle, the appropriateness of using pristine nanomaterials in environmental testing is being questioned. Using a combination of transmission electron microscopy (TEM), energy dispersive X-ray spectroscopy (EDS), X-ray photoelectron spectroscopy (XPS), and inductively coupled plasma-mass spectrometry (ICP-MS), this work examines the morphological and compositional effects of conditions mimicking a typical lifecycle of a nano-enabled product, from the production of the silver nanoparticle (AgNP)-laden textiles, through its use, laundering, and then finally, its leaching and incubation in the wastewater collection system. These simulated weathering conditions showed evidence for the transformation of AgNPs into AgCl and Ag2S. Incubation in raw wastewater had the most dramatic effect on the AgNPs in terms of transformation, no matter what initial weathering was applied to the NPs prior to incubation. However, despite extensive transformation noted, AgNPs were still present within all the samples after the use scenarios.
- Published
- 2019
- Full Text
- View/download PDF
19. Polymer Brush–GaAs Interface and Its Use as an Antibody-Compatible Platform for Biosensing
- Author
-
Maria C. DeRosa, Walid M. Hassen, Juliana Chawich, Jan J. Dubowski, Khalid Moumanis, Daniela T Marquez, Laboratoire Nanotechnologies et Nanosystèmes [Sherbrooke] (LN2), Université de Sherbrooke (UdeS)-École Centrale de Lyon (ECL), Université de Lyon-Université de Lyon-École supérieure de Chimie Physique Electronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Institut Interdisciplinaire d'Innovation Technologique [Sherbrooke] (3IT), and Université de Sherbrooke (UdeS)
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Materials science ,[SDV]Life Sciences [q-bio] ,General Chemical Engineering ,Interface (computing) ,Nanotechnology ,02 engineering and technology ,010402 general chemistry ,Polymer brush ,01 natural sciences ,Article ,QD1-999 ,ComputingMilieux_MISCELLANEOUS ,chemistry.chemical_classification ,Atom-transfer radical-polymerization ,Biomolecule ,nutritional and metabolic diseases ,General Chemistry ,Polymer ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,Chemistry ,chemistry ,Compatibility (mechanics) ,Surface modification ,0210 nano-technology ,Biosensor - Abstract
Despite evidence showing that polymer brushes (PBs) are a powerful tool used in biosensing for minimizing nonspecific interactions, allowing for optimization of biosensing performance, and the fact that GaAs semiconductors have proven to have a remarkable potential for sensitive biomolecule detection, the combination of these two robust components has never been considered nor evaluated as a platform for biosensing applications. This work reports different methodologies to prepare and tune PBs on the GaAs interface (PB–GaAs) and their potential as useful platforms for antibody grafting, with the ultimate goal of demonstrating the innovative and attractive character of the PB–GaAs interfaces in the enhanced capture of antibodies and control of nonspecific interactions. Three different functionalization approaches were explored, one “grafting-to” and two “grafting-from,” in which atom transfer radical polymerization (ATRP) was performed, followed by their corresponding characterizations. Demonstration of the compatibility of Escherichia coli (E. coli) and Legionella pneumophila (Lp) antibodies with the PB–GaAs platform compared to the results obtained with conventional biosensing architectures developed for GaAs indicates the attractive potential for operation of a sensitive biosensor. Furthermore, these results showed that by carefully choosing the nature and preparation methodology of a PB–GaAs interface, it is possible to effectively tune the affinity of PB–GaAs-based sensors toward E. coli and Lp antibodies ultimately demonstrating the superior specificity of the developed biosensing platform.
- Published
- 2021
- Full Text
- View/download PDF
20. Developments in mycotoxin analysis: an update for 2019-2020
- Author
-
Chris M. Maragos, Sheryl A. Tittlemier, J. Brunkhorst, Benedikt Cramer, Mark W. Sumarah, M. Stranska, Maria C. DeRosa, Veronica M.T. Lattanzio, and R.J. Malone
- Subjects
0303 health sciences ,Engineering ,Management science ,business.industry ,010401 analytical chemistry ,technology, industry, and agriculture ,Public Health, Environmental and Occupational Health ,Toxicology ,01 natural sciences ,0104 chemical sciences ,03 medical and health sciences ,chemistry.chemical_compound ,chemistry ,Mycotoxin ,business ,030304 developmental biology ,Food Science - Abstract
This review summarises developments on the analysis of various matrices for mycotoxins published in the period from mid-2019 to mid-2020. Notable developments in all aspects of mycotoxin analysis, from sampling and quality assurance/quality control of analytical results, to the various detection and quantitation technologies ranging from single mycotoxin biosensors to comprehensive instrumental methods are presented and discussed. Aside from sampling and quality control, discussion of this past year’s developments is organised by detection and quantitation technology and covers chromatography with targeted or non-targeted high resolution mass spectrometry, tandem mass spectrometry, detection other than mass spectrometry, biosensors, as well as assays that use alternatives to antibodies. This critical review aims to briefly present the most important recent developments and trends in mycotoxin determination as well as to address limitations of the presented methodologies.
- Published
- 2021
- Full Text
- View/download PDF
21. Aptamer-Modified Ultrastable Gold Nanoparticles for Dopamine Detection
- Author
-
Shimwe Dominique Niyonambaza, Mounir Boukadoum, Elodie Boisselier, Anna Koudrina, Amine Miled, and Maria C. DeRosa
- Subjects
Chemistry ,Aptamer ,010401 analytical chemistry ,Nanoparticle ,Nanotechnology ,Ascorbic acid ,01 natural sciences ,0104 chemical sciences ,Colloidal gold ,Dopamine ,medicine ,Molecule ,Electrical and Electronic Engineering ,Surface plasmon resonance ,Instrumentation ,Plasmon ,medicine.drug - Abstract
Metallic nanoparticles, in particular silver and gold nanoparticles, have been used in various fields for centuries. In the last few decades, their plasmon resonance has made them particularly attractive to biochemists because of their unparalleled optical properties, making them ideal probes for molecular detection. In this article, a new approach to dopamine detection based on ultrastable gold nanoparticles is presented. A dopamine-binding aptamer was used to modify ultrastable gold nanoparticles for the sensitive and selective detection of different concentrations of dopamine without inducing gold nanoparticles aggregation. Indeed, when dopamine binds to the aptamer present at the surface of the gold nanoparticle, the latter exhibits a plasmon shift relative to the dopamine concentration, allowing measurement of its dosage. Besides that, the target molecules can be filtered out to permit nanoparticles reuse. The detection assay showed good linearity between the dopamine concentration and gold nanoparticles’ plasmon shift while common interfering molecules, such as ascorbic acid and tyramine, induced no or little plasmon shift.
- Published
- 2021
- Full Text
- View/download PDF
22. Exploring the Unique Contrast Properties of Aptamer–Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi
- Author
-
Greg O. Cron, Maria C. DeRosa, Anna Koudrina, Erin M. McConnell, Suzan Chen, Eve C. Tsai, and Joseph A. Zurakowski
- Subjects
Materials science ,Aptamer ,Gadolinium ,Contrast Media ,chemistry.chemical_element ,Fibrinogen ,Proof of Concept Study ,Fibrin ,03 medical and health sciences ,0302 clinical medicine ,Coordination Complexes ,medicine ,Humans ,General Materials Science ,Thrombus ,030304 developmental biology ,Whole blood ,0303 health sciences ,biology ,Microscale thermophoresis ,Thrombosis ,Aptamers, Nucleotide ,medicine.disease ,Magnetic Resonance Imaging ,chemistry ,Biophysics ,biology.protein ,Molecular imaging ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Objective: An important clinical question in the determination of the extent of thrombosis-related vascular conditions is the identification of blood clot location. Fibrin is a major molecular constituent of blood clots and can, therefore, be utilized in molecular imaging. In this proof-of-concept study, we sought to prepare a fibrin-targeting magnetic resonance imaging contrast agent, using a Gd(III)-loaded fibrinogen aptamer (FA) chelate conjugate (Gd(III)-NOTA-FA) (NOTA = 1,4,7-triazacyclononane-1,4,7-triacetic acid), to endow the ability to specifically accumulate at the location of blood clots, thereby enhancing contrast capabilities. Methods: The binding affinity of FA for fibrin was confirmed by fluorescence microscopy and microscale thermophoresis. The preparation and effective loading of the chelate-aptamer conjugates were confirmed by mass spectrometry and a xylenol orange colorimetric test. Longitudinal and transverse relaxivities and the effects of target binding were assessed using T1- and T2-map sequences at 7 T. T1- and T2-weighted images were acquired after blood clots were treated with Gd(III)-NOTA-FA. Collagen was used as the protein control, while an unrelated aptamer sequence, FB139, was used as the aptamer control. Results: FA demonstrated a high affinity and selectivity toward the polymeric protein, with a Kd of 16.6 nM, confirming an avidity over fibrinogen. The longitudinal (r1) and transverse (r2) relaxivities of Gd(III)-NOTA-FA demonstrated that conjugation to the long aptamer strand shortened T1 relaxation times and increased T2 relaxation times (3.04 and 38.7 mM-1 s-1, respectively). These effects were amplified by binding to the fibrin target (1.73 and 46.5 mM-1 s-1, respectively). In vitro studies with thrombin-polymerized human blood (clots) in whole blood showed an unexpected enhancement of signal intensity (hyperintense) produced exclusively at the location of the clot during the T2-weighted scan, while the presence of fibrinogen within a whole blood pool resulted in T1 signal intensity enhancement throughout the pool. This is advantageous, as simply reversing the type of a scan from a typical T1-weighted to a T2-weighted would allow to selectively highlight the location of blood clots. Conclusions: Gd(III)-NOTA-FA can be used for molecular imaging of thrombi, through fibrin-targeted delivery of contrast to the location of blood clots in T2-weighted scans.
- Published
- 2021
- Full Text
- View/download PDF
23. Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications
- Author
-
Annamaria eRuscito and Maria C. DeRosa
- Subjects
small molecule ,biosensor ,aptamer ,SELEX ,in vitro selection ,Chemistry ,QD1-999 - Abstract
Aptamers are single-stranded, synthetic oligonucleotides that fold into 3-dimensional shapes capable of binding non-covalently with high affinity and specificity to a target molecule. They are generated via an in vitro process known as the Systematic Evolution of Ligands by EXponential enrichment, from which candidates are screened and characterized, and then applied in aptamer-based biosensors for target detection. Aptamers for small molecule targets such as toxins, antibiotics, molecular markers, drugs, and heavy metals will be the focus of this review. Their accurate detection is ultimately needed for the protection and wellbeing of humans and animals. However, issues such as the drastic difference in size of the aptamer and small molecule make it challenging to select, characterize, and apply aptamers for the detection of small molecules. Thus, recent (since 2012) notable advances in small molecule aptamers, which have overcome some of these challenges, are presented here, while defining challenges that still exist are discussed
- Published
- 2016
- Full Text
- View/download PDF
24. Laparoscopic-guided versus transincisional rectus sheath block for pediatric single-incision laparoscopic cholecystectomy: A randomized controlled trial
- Author
-
Paul D. Danielson, Sandra M. Farach, Nicole M. Chandler, Cristen N. Litz, Jo Ann C. DeRosa, Raquel Gonzalez, Ernest K. Amankwah, Jeremy D. Kauffman, and Anh Thy H. Nguyen
- Subjects
Adult ,Male ,Adolescent ,Biliary Tract Diseases ,medicine.medical_treatment ,Pacu ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,medicine ,Humans ,Child ,Adverse effect ,biology ,business.industry ,Abdominal Wall ,Nerve Block ,General Medicine ,Rectus sheath ,biology.organism_classification ,medicine.disease ,Exact test ,medicine.anatomical_structure ,Cholecystectomy, Laparoscopic ,030220 oncology & carcinogenesis ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Morphine ,Pancreatitis ,Female ,Surgery ,Cholecystectomy ,business ,medicine.drug - Abstract
Purpose The purpose of our study was to compare the effectiveness of transincisional (TI) versus laparoscopic-guided (LG) rectus sheath block (RSB) for pain control following pediatric single-incision laparoscopic cholecystectomy (SILC). Methods Forty-eight patients 10–21 years old presenting to a single institution for SILC from 2015 to 2018 were randomized to TI or LG RSB. Apart from RSB technique, perioperative care protocols were identical between groups. Pain scores were assessed with validated measures upon arrival in the postanesthesia care unit (PACU) and at regular intervals until discharge. The patients and those assessing them were blinded to RSB technique. The primary outcome was pain score 60 min after PACU arrival. Secondary outcomes included pain scores throughout the PACU stay, opioids (reported as morphine milligram equivalents (MME) per kg bodyweight) administered in PACU, length of stay, outpatient pain scores and opioid use, and adverse events. Groups were compared on outcomes using t test and generalized estimating equations for continuous variables and Fisher's exact test for categorical variables with significance at α = 0.05. Results Mean age of the 48 subjects was 15 years (range = 11–20). The majority (79%) were female. Indications for surgery included symptomatic cholelithiasis (n = 41), acute cholecystitis (n = 4), gallstone pancreatitis (n = 2) and choledocholithiasis (n = 1). Mean (standard deviation) operative time was 61 (± 23) min overall. No statistically significant differences in demographics, indication, operative time, or intraoperative analgesia were observed between TI (n = 24) and LG (n = 24) groups. The mean 60-min pain score was 3.4 (± 2.6) in the LG group versus 3.8 (± 2.1) in the TI group (p = 0.573). No significant differences were detected between groups in overall PACU or outpatient pain scores, PACU or outpatient opioid use, length of stay, or incidence of complications. Overall, mean opioid use was 0.1 MME/kg in the PACU and 0.5 MME/kg in the outpatient setting. Mean postoperative length of stay was 0.2 day. There were no major complications. Conclusion Laparoscopic-guided rectus sheath block is not superior to transincisional rectus sheath block for pain control following pediatric single-incision laparoscopic cholecystectomy. The single-incision laparoscopic approach combined with rectus sheath block resulted in effective pain control, low opioid use, and expedited length of stay with no major complications. Level of evidence Level I, treatment study, randomized controlled trial.
- Published
- 2020
- Full Text
- View/download PDF
25. External caliper-based measurements of the modified percent depth as an alternative to cross-sectional imaging for assessing the severity of pectus excavatum
- Author
-
Christopher W. Snyder, Bryce M. Bludevich, Paul D. Danielson, Kevin Potthast, Jo Ann C. DeRosa, Jeremy D. Kauffman, Kristin Wharton, Sandra M. Farach, Nicole M. Chandler, and Cristen N. Litz
- Subjects
Adult ,Male ,Adolescent ,Correlation coefficient ,Cost effectiveness ,Physical examination ,Sensitivity and Specificity ,Severity of Illness Index ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Cohen's kappa ,Pectus excavatum ,030225 pediatrics ,medicine ,Humans ,Body Weights and Measures ,Prospective Studies ,Child ,Physical Examination ,medicine.diagnostic_test ,business.industry ,Reproducibility of Results ,General Medicine ,medicine.disease ,Inter-rater reliability ,ROC Curve ,Funnel Chest ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Calipers ,Female ,Surgery ,Haller index ,Tomography, X-Ray Computed ,Nuclear medicine ,business - Abstract
Cross-sectional imaging (CSI) may be clinically unnecessary in the evaluation of pectus excavatum (PE). The purpose of our study was to prospectively evaluate the accuracy and reliability of the modified percent depth (MPD), derived from caliper-based external measurements, in identifying PE.Children 11-21 years old presenting for evaluation of PE or to obtain thoracic cross-sectional imaging for other indications were measured to derive the Modified Percent Depth. The Haller Index (HI) and Correction Index (CI) were calculated from CSI. Receiver-Operator Characteristic (ROC) analysis was used to compare the sensitivity and specificity of MPD, HI, and CI. Interrater reliability was assessed using Spearman's correlation coefficient and Cohen's Kappa coefficient.Of 199 patients, 76 (38%) had severe PE. Median age was 16 years (range = 11-21). The median Modified Percent Depth was 21.4% (IQR = 16.2-26.3) among those with PE versus 4.1% (IQR = 1.7-6.4) in those without (p 0.001). MPD ≥ 11% exhibited similar sensitivity and specificity to HI ≥ 3.25 and CI ≥ 10 for identifying PE (ROC 0.98 vs. 0.97 vs. 0.98, respectively, p = 0.41). With respect to interrater reliability, independent clinicians' caliper measurements exhibited 87% agreement when identifying MPD ≥ 11% (p 0.001) with excellent correlation (Spearman's ρ 0.71, p 0.001).Caliper-based, physical examination measurements of the Modified Percent Depth reliably identify pectus excavatum and represent an alternative to CSI-based measurements for the assessment of PE.Diagnostic test.Level II.
- Published
- 2020
- Full Text
- View/download PDF
26. Fibrinogen aptamer functionalized gold-coated iron-oxide nanoparticles for targeted imaging of thrombi
- Author
-
Anna Koudrina, Celine Chartrand, Greg O Cron, Jonathan O’Brien, Eve C Tsai, and Maria C DeRosa
- Subjects
Metals and Alloys ,Fibrinogen ,Thrombosis ,General Chemistry ,Aptamers, Nucleotide ,Magnetic Resonance Imaging ,Catalysis ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials ,Materials Chemistry ,Ceramics and Composites ,Humans ,Magnetic Iron Oxide Nanoparticles ,Gold ,circulatory and respiratory physiology - Abstract
Targeting of molecular constituents of thrombi with aptamer functionalized core-shell nanoparticles (CSN) allowed for high resolution clot delineation in T2-weighted magnetic resonance imaging. Meanwhile, the gold-coating demonstrated sufficient contrast capabilities in computed tomography (1697 HU μM
- Published
- 2022
27. pH-Control in Aptamer-Based Diagnostics, Therapeutics, and Analytical Applications
- Author
-
Micaela Belleperche and Maria C. DeRosa
- Subjects
aptamer ,pH-responsive ,drug delivery ,biosensors ,DNA nanotechnology ,i-motif ,triplex ,Medicine ,Pharmacy and materia medica ,RS1-441 - Abstract
Aptamer binding has been used effectively for diagnostics, in-vivo targeting of therapeutics, and the construction and control of nanomachines. Nanostructures that respond to pH by releasing or changing affinity to a target have also been used for in vivo delivery, and in the construction of sensors and re-usable nanomachines. There are many applications that use aptamers together with pH-responsive materials, notably the targeted delivery of chemotherapeutics. However, the number of reported applications that directly use pH to control aptamer binding is small. In this review, we first discuss the use of aptamers with pH-responsive nanostructures for chemotherapeutic and other applications. We then discuss applications that use pH to denature or otherwise disrupt the binding of aptamers. Finally, we discuss motifs using non-canonical nucleic acid base pairing that can shift conformation in response to pH, followed by an overview of engineered pH-controlled aptamers designed using those motifs.
- Published
- 2018
- Full Text
- View/download PDF
28. Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
- Author
-
Catherine A Cosgrove, Charles J Lacey, Alethea V Cope, Angela Bartolf, Georgina Morris, Celine Yan, Susan Baden, Tom Cole, Darrick Carter, Elizabeth Brodnicki, Xiaoying Shen, Sarah Joseph, Stephen C DeRosa, Lili Peng, Xuesong Yu, Guido Ferrari, Mike Seaman, David C Montefiori, Nicole Frahm, Georgia D Tomaras, Wolfgang Stöhr, Sheena McCormack, and Robin J Shattock
- Subjects
Medicine ,Science - Abstract
BackgroundDefining optimal routes for induction of mucosal immunity represents an important research priority for the HIV-1 vaccine field. In particular, it remains unclear whether mucosal routes of immunization can improve mucosal immune responses.MethodsIn this randomized two center phase I clinical trial we evaluated the systemic and mucosal immune response to a candidate HIV-1 Clade C CN54gp140 envelope glycoprotein vaccine administered by intramuscular (IM), intranasal (IN) and intravaginal (IVAG) routes of administration in HIV negative female volunteers. IM immunizations were co-administered with Glucopyranosyl Lipid Adjuvant (GLA), IN immunizations with 0.5% chitosan and IVAG immunizations were administered in an aqueous gel.ResultsThree IM immunizations of CN54 gp140 at either 20 or 100 μg elicited significantly greater systemic and mucosal antibodies than either IN or IVAG immunizations. Following additional intramuscular boosting we observed an anamnestic antibody response in nasally primed subjects. Modest neutralizing responses were detected against closely matched tier 1 clade C virus in the IM groups. Interestingly, the strongest CD4 T-cell responses were detected after IN and not IM immunization.ConclusionsThese data show that parenteral immunization elicits systemic and mucosal antibodies in women. Interestingly IN immunization was an effective prime for IM boost, while IVAG administration had no detectable impact on systemic or mucosal responses despite IM priming.Clinical trials registrationEudraCT 2010-019103-27 and the UK Clinical Research Network (UKCRN) Number 11679.
- Published
- 2016
- Full Text
- View/download PDF
29. Envisioning the scientific paper of the future
- Author
-
Laura E. Coristine, Chelsea M. Rochman, Brian L. Owens, Natalie Sopinka, Steven J. Cooke, and Maria C. DeRosa
- Subjects
science writing ,0303 health sciences ,Open science ,Engineering ,Multidisciplinary ,business.industry ,05 social sciences ,science communication ,Epistemology ,Moment (mathematics) ,03 medical and health sciences ,Scientific literacy ,open science ,scholarly publishing ,Science communication ,lcsh:Q ,0509 other social sciences ,lcsh:L ,lcsh:Science ,050904 information & library sciences ,business ,Science writing ,lcsh:Education ,030304 developmental biology - Abstract
Consider for a moment the rate of advancement in the scientific understanding of DNA. It is formidable; from Fredrich Miescher’s nuclein extraction in the 1860s to Rosalind Franklin’s double helix X-ray in the 1950s to revolutionary next-generation sequencing in the late 2000s. Now consider the scientific paper, the medium used to describe and publish these advances. How is the scientific paper advancing to meet the needs of those who generate and use scientific information? We review four essential qualities for the scientific paper of the future: ( i) a robust source of trustworthy information that remains peer reviewed and is ( ii) communicated to diverse users in diverse ways, ( iii) open access, and ( iv) has a measurable impact beyond Impact Factor. Since its inception, scientific literature has proliferated. We discuss the continuation and expansion of practices already in place including: freely accessible data and analytical code, living research and reviews, changes to peer review to improve representation of under-represented groups, plain language summaries, preprint servers, evidence-informed decision-making, and altmetrics.
- Published
- 2020
- Full Text
- View/download PDF
30. Quality Initiative Using Theory of Change and Visual Analytics to Improve Controlled Substance Documentation Discrepancies in the Operating Room
- Author
-
Hannah Lonsdale, Luis M. Ahumada, Allison M Fernandez, Amish Patel, Mohamed Rehman, Ali Jalali, Anna M. Varughese, Jenny E. Dolan, Jacquelin Peck, Joann C. Derosa, and Jibin Samuel
- Subjects
Operating Rooms ,Controlled substance ,Visual analytics ,Time Factors ,Quality management ,Process management ,Controlled Substances ,Computer science ,business.industry ,Statistics as Topic ,Dashboard (business) ,Health Informatics ,Documentation ,Audit ,Quality Improvement ,Health informatics ,Computer Science Applications ,Health Information Management ,Analytics ,Humans ,Child ,business - Abstract
Background Discrepancies in controlled substance documentation are common and can lead to legal and regulatory repercussions. We introduced a visual analytics dashboard to assist in a quality improvement project to reduce the discrepancies in controlled substance documentation in the operating room (OR) of our free-standing pediatric hospital. Methods Visual analytics were applied to collected documentation discrepancy audit data and were used to track progress of the project, to motivate the OR team, and in analyzing where further improvements could be made. This was part of a seven-step improvement plan based on the Theory of Change with a logic model framework approach. Results The introduction of the visual analytics dashboard contributed a 24% improvement in controlled substance documentation discrepancy. The project overall reduced documentation errors by 71% over the studied period. Conclusion We used visual analytics to simultaneously analyze, monitor, and interpret vast amounts of data and present them in an appealing format. In conjunction with quality-improvement principles, this led to a significant improvement in controlled substance documentation discrepancies.
- Published
- 2019
- Full Text
- View/download PDF
31. High-sensitivity detection of metastatic breast cancer cells via terahertz chemical microscopy using aptamers
- Author
-
Maria C. DeRosa, Ahmed Mohamed, Toshihiko Kiwa, William G. Willmore, Tsuneyuki Ozaki, Yuki Hanaoka, and Eman M. Hassan
- Subjects
biology ,Terahertz radiation ,Chemistry ,Aptamer ,Metals and Alloys ,Mammaglobin B ,Condensed Matter Physics ,medicine.disease ,Metastatic breast cancer ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials ,Mammaglobin ,Mammaglobin-A ,Microscopy ,Materials Chemistry ,Cancer research ,medicine ,biology.protein ,Electrical and Electronic Engineering ,skin and connective tissue diseases ,Instrumentation ,Normal breast - Abstract
We demonstrate high-sensitivity detection of metastatic breast cancer cells using terahertz (THz) chemical microscopy (TCM) with aptamers as ligands. For the aptamers, we use previously developed synthetic single stranded (ss) DNA aptamers mammaglobin B1 (MAMB1) and mammaglobin A2 (MAMA2) that bind to mammaglobin B and mammaglobin A proteins, respectively, which are overexpressed on the surface of MCF7 and MDA-MB-415 breast cancer cells. Each aptamer was immobilized on the surface of a sensing plate, and the amplitude of the THz signal was measured upon the binding of each aptamer to different number (10–106) of its target breast cancer cells. A change in the THz amplitude was observed when MAMB1 and MAMA2 bind to MCF7 and MDA-MB-415, respectively. We find that this change was linear as a function of the log number of breast cancer cells used. No change in the THz amplitude was observed when the same number of normal breast cells (MCF 10A) were used. Moreover, MAMB1 and MAMA2 did not show binding to the counter breast cancer cells, indicating high selectivity. We have demonstrated that the TCM using aptamers as ligands has a limit of detection as small as 1 breast cancer cell in 100 μL of sample. Results described here indicate that the TCM could be a powerful tool to detect metastatic breast cancer cells.
- Published
- 2019
- Full Text
- View/download PDF
32. Synthesis, transfer, and characterization of core-shell gold-coated magnetic nanoparticles
- Author
-
Maureen McKeague, Maria C. DeRosa, and McKenzie Smith
- Subjects
Gold-coated ,Materials science ,Absorption spectroscopy ,Clinical Biochemistry ,Nanoparticle phase transfer ,Nanoparticle ,Aqueous phase transfer ,4-Dimethyl(amino)pyridine ,010501 environmental sciences ,TMAOH, tetramethylammonium hydroxide ,01 natural sciences ,HR-TEM, high-resolution transmission electron microscopy ,Magnetic separation ,Fe3O4-AuNPs ,03 medical and health sciences ,chemistry.chemical_compound ,Synthesis ,Solvothermal synthesis of iron oxide nanoparticles with direct gold coating to form core-shell gold-coated magnetic nanoparticles ,Pyridine ,Iron oxide ,Solvothermal ,Solubility ,Thin gold coating ,lcsh:Science ,030304 developmental biology ,0105 earth and related environmental sciences ,ComputingMethodologies_COMPUTERGRAPHICS ,Core-shell ,0303 health sciences ,Aqueous solution ,DMAP, 4-dimethyl(amino)pyridine ,Fe3O4-AuNPs, core-shell gold-coated magnetic nanoparticles ,Phase transfer of core-shell gold-coated magnetic nanoparticles from organic to aqueous using 4-(dimethyl)amino pyridine (DMAP) as a phase transfer agent ,Medical Laboratory Technology ,Chemistry ,chemistry ,Chemical engineering ,(HR-TEM/EDS), high-resolution transmission electron microscopy with energy-dispersive X-ray spectroscopy ,DMAP ,Transmission electron microscopy ,Core-shell gold-coated magnetic nanoparticles ,Magnetic nanoparticles ,lcsh:Q ,Phase-transfer catalyst - Abstract
Graphical abstract, Magnetic separation has gained new popularity as a versatile partitioning method with the recent growth in nanotechnology and related biotechnology applications. In this study, iron oxide magnetic nanoparticles were synthesized via solvothermal methods and directly coated with gold to form core-shell gold-coated magnetic nanoparticles (Fe3O4-AuNPs). High-resolution transmission electron microscopy with Energy dispersive X-ray spectroscopy results suggests that temperature and reaction time play an important role in the formation of small, monodisperse Fe3O4-AuNPs. We also demonstrate that increased 4- dimethyl(amino)pyridine (DMAP) concentrations and vigorous stirring were required to successfully transfer Fe3O4-AuNPs into aqueous solution. The structure and morphology of the synthesized and transferred Fe3O4-AuNPs was further confirmed by UV–vis absorption spectroscopy and solubility experiments. • Direct coating of Fe3O4 with Au: Slowly heating by (10 °C/ min) until 180–190 °C without exceeding this reaction temperature and increasing the reaction time to 3 h from 1.5 h • High yield transfer of Fe3O4-AuNPs was achieved using 4- dimethyl(amino)pyridine (DMAP) as phase transfer catalyst
- Published
- 2019
33. Selection of DNA Aptamers for Root Exudate l-Serine Using Multiple Selection Strategies
- Author
-
Carlos M. Monreal, Maria C. DeRosa, Kathryn Cyr, and Emily Mastronardi
- Subjects
0106 biological sciences ,Library ,Aptamer ,Computational biology ,01 natural sciences ,chemistry.chemical_compound ,Serine ,Selection (genetic algorithm) ,Gene Library ,2. Zero hunger ,Nuclease ,biology ,010401 analytical chemistry ,SELEX Aptamer Technique ,food and beverages ,General Chemistry ,Exudates and Transudates ,Aptamers, Nucleotide ,Small molecule ,0104 chemical sciences ,chemistry ,biology.protein ,General Agricultural and Biological Sciences ,Biosensor ,DNA ,Systematic evolution of ligands by exponential enrichment ,010606 plant biology & botany - Abstract
Agricultural biosensing can aid decisions about crop health and maintenance, because crops release root exudates that can inform about their status. l-Serine has been found to be indicative of nitrogen uptake in wheat and canola. The development of a biosensor for l-serine could allow farmers to monitor crop nutrient demands more precisely. The development of robust l-serine-binding DNA aptamers is described. Because small molecules can be challenging targets for Systematic Evolution of Ligands by EXponential enrichment (SELEX), three separate DNA libraries were used for SELEX experiments. A l-homocysteine aptamer was randomized to create a starting library for a l-serine selection (randomized SELEX). The final selection rounds of the l-homocysteine selection were also used as a starting library for l-serine (redirected SELEX). Finally, an original DNA library was used (original SELEX). All three SELEX experiments produced l-serine-binding aptamers with micromolar affinity, with Red.1 aptamer having a Kd of 7.9 ± 3.6 μM. Truncation improved the binding affinity to 5.2 ± 2.7 μM, and from this sequence, a Spiegelmer with improved nuclease resistance was created with a Kd of 2.0 ± 0.8 μM. This l-serine-binding Spiegelmer has the affinity and stability to be incorporated into aptamer-based biosensors for agricultural applications.
- Published
- 2021
34. Aptamer base: a collaborative knowledge base to describe aptamers and SELEX experiments.
- Author
-
Jose Cruz-Toledo, Maureen McKeague, Xueru Zhang, Amanda Giamberardino, Erin McConnell, Tariq Francis, Maria C. DeRosa, and Michel Dumontier
- Published
- 2012
- Full Text
- View/download PDF
35. A review of Cryptosporidium spp. and their detection in water
- Author
-
Asma Iqbal, Syed A Sattar, Brent R. Dixon, Eman M. Hassan, Banu Örmeci, and Maria C. DeRosa
- Subjects
Cryptosporidium parvum ,0303 health sciences ,Environmental Engineering ,030306 microbiology ,Aptamer ,Oocysts ,Cryptosporidiosis ,Cryptosporidium ,Water ,Biology ,DNA Aptamers ,biology.organism_classification ,Microbiology ,law.invention ,03 medical and health sciences ,Water matrix ,law ,parasitic diseases ,Animals ,Polymerase chain reaction ,030304 developmental biology ,Water Science and Technology - Abstract
Cryptosporidium spp. are one of the most important waterborne pathogens worldwide and a leading cause of mortality from waterborne gastrointestinal diseases. Detection of Cryptosporidium spp. in water can be very challenging due to their low numbers and the complexity of the water matrix. This review describes the biology of Cryptosporidium spp. and current methods used in their detection with a focus on C. parvum and C. hominis. Among the methods discussed and compared are microscopy, immunology-based methods using monoclonal antibodies, molecular methods including PCR (polymerase chain reaction)-based assays, and emerging aptamer-based methods. These methods have different capabilities and limitations, but one common challenge is the need for better sensitivity and specificity, particularly in the presence of contaminants. The application of DNA aptamers in the detection of Cryptosporidium spp. oocysts shows promise in overcoming these challenges, and there will likely be significant developments in aptamer-based sensors in the near future.
- Published
- 2021
36. Plasmonic optical fiber grating biomedical aptasensor
- Author
-
Maria C. DeRosa, Erik Goormaghtigh, Ruddy Wattiez, Karima Chah, Christophe Caucheteur, Maxime Lobry, Eman M. Hassan, and Médéric Loyez
- Subjects
Optical fiber ,Materials science ,genetic structures ,business.industry ,technology, industry, and agriculture ,Negative control ,Grating ,law.invention ,Biomarker ,law ,Optical sensing ,Optoelectronics ,skin and connective tissue diseases ,business ,neoplasms ,Biosensor ,Plasmon - Abstract
A plasmonic optical fiber grating aptasensor was developed for real-time detection of the HER2 breast cancer biomarker. The designed biosensor shows an accurate and selective sensing of HER2 with respect to a biomarker negative control.
- Published
- 2021
- Full Text
- View/download PDF
37. HER2 breast cancer biomarker detection using a sandwich optical fiber assay
- Author
-
Christophe Caucheteur, Ruddy Wattiez, Médéric Loyez, Eman M. Hassan, Maria C. DeRosa, and Maxime Lobry
- Subjects
optical fiber ,Optical fiber ,Aptamer ,Biochimie ,aptamers ,Breast Neoplasms ,02 engineering and technology ,Biosensing Techniques ,Sciences de l'ingénieur ,01 natural sciences ,Signal ,Analytical Chemistry ,law.invention ,law ,HER2 ,Biomarkers, Tumor ,Humans ,Surface plasmon resonance ,Plasmon ,Optical Fibers ,Reproducibility ,Chemistry ,business.industry ,010401 analytical chemistry ,breast cancer diagnosis ,Reproducibility of Results ,Surface Plasmon Resonance ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,biomarker ,Optoelectronics ,0210 nano-technology ,business ,Refractive index ,Biosensor - Abstract
Optical fiber-based surface plasmon resonance (OF-SPR) sensors have demonstrated high versatility and performances over the last years, which propelled the technique to the heart of numerous and original biosensing concepts. In this work, we contribute to this effort and present our recent findings about the detection of breast cancer HER2 biomarkers through OF-SPR optrodes. 1 cm-long sections of 400 μm core-diameter optical fibers were covered with a sputtered gold film, yielding enhanced sensitivity to surface refractive index changes. Studying the impacts of the gold film thickness on the plasmonic spectral response, we improved the quality and reproducibility of the sensors. These achievements were correlated in two ways, using both the central wavelengths of the plasmon resonance and its influence on the bulk refractive index sensitivity. Our dataset was fed by additional biosensing experiments with a direct and indirect approach, relying on aptamers and antibodies specifically implemented in a sandwich layout. HER2 biomarkers were specifically detected at 0.6 μg/mL (5.16 nM) in label-free while the amplification with HER2-antibodies provided a nearly hundredfold signal magnification, reaching 9.3 ng/mL (77.4 pM). We believe that these results harbinger the way for their further use in biomedical samples.
- Published
- 2021
38. Ultrasensitive norovirus detection using DNA aptasensor technology.
- Author
-
Amanda Giamberardino, Mahmoud Labib, Eman M Hassan, Jason A Tetro, Susan Springthorpe, Syed A Sattar, Maxim V Berezovski, and Maria C DeRosa
- Subjects
Medicine ,Science - Abstract
DNA aptamers were developed against murine norovirus (MNV) using SELEX (Systematic Evolution of Ligands by EXponential enrichment). Nine rounds of SELEX led to the discovery of AG3, a promising aptamer with very high affinity for MNV as well as for lab-synthesized capsids of a common human norovirus (HuNoV) outbreak strain (GII.3). Using fluorescence anisotropy, AG3 was found to bind with MNV with affinity in the low picomolar range. The aptamer could cross-react with HuNoV though it was selected against MNV. As compared to a non-specific DNA control sequence, the norovirus-binding affinity of AG3 was about a million-fold higher. In further tests, the aptamer also showed nearly a million-fold higher affinity for the noroviruses than for the feline calicivirus (FCV), a virus similar in size and structure to noroviruses. AG3 was incorporated into a simple electrochemical sensor using a gold nanoparticle-modified screen-printed carbon electrode (GNPs-SPCE). The aptasensor could detect MNV with a limit of detection of approximately 180 virus particles, for possible on-site applications. The lead aptamer candidate and the aptasensor platform show promise for the rapid detection and identification of noroviruses in environmental and clinical samples.
- Published
- 2013
- Full Text
- View/download PDF
39. Comparison of In-Solution Biorecognition Properties of Aptamers against Ochratoxin A
- Author
-
Maureen McKeague, Ranganathan Velu, Annalisa De Girolamo, Stefania Valenzano, Michelangelo Pascale, McKenzie Smith, and Maria C. DeRosa
- Subjects
aptamer ,ochratoxin A ,mycotoxins ,biorecognition ,fluorescent assay ,biosensing ,aptasensor ,microscale thermophoresis ,Medicine - Abstract
Ochratoxin A (OTA) is a mycotoxin produced as a secondary metabolite by several species of Aspergillus and Penicillium and frequently found as a natural contaminant in a wide range of food commodities. Novel and robust biorecognition agents for detecting this molecule are required. Aptamers are artificial nucleic acid ligands able to bind with high affinity and specificity to a given target molecule. In the last few years, three separate research groups have selected aptamers for ochratoxin A. While each of these three families of aptamers have been incorporated into various methods for detecting OTA, it is unclear if each aptamer candidate is better suited for a particular application. Here, we perform the first head-to-head comparison of solution-based binding parameters for these groups of aptamers. Based on our results, we provide recommendations for the appropriate choice of aptamer for incorporation into solution-based biorecognition assays and applications.
- Published
- 2016
- Full Text
- View/download PDF
40. Assessment of Aptamer-Targeted Contrast Agents for Monitoring of Blood Clots in Computed Tomography and Fluoroscopy Imaging
- Author
-
Roberto Garcia, Peter Kan, Maria C. DeRosa, Spencer Boisjoli, Anna Koudrina, Eve C. Tsai, and Jonathan O'Brien
- Subjects
Swine ,Biomedical Engineering ,Pharmaceutical Science ,Contrast Media ,Bioengineering ,02 engineering and technology ,Fibrinogen ,01 natural sciences ,Imaging phantom ,Fibrin ,Iopamidol ,medicine ,Animals ,Humans ,Pharmacology ,biology ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Thrombosis ,Blood flow ,Aptamers, Nucleotide ,021001 nanoscience & nanotechnology ,medicine.disease ,0104 chemical sciences ,Pulmonary embolism ,Fluoroscopy ,biology.protein ,0210 nano-technology ,Tomography, X-Ray Computed ,Perfusion ,Ex vivo ,Biotechnology ,medicine.drug ,Biomedical engineering - Abstract
Objective: Random formation of thrombi is classified as a pathological process that may result in partial or complete obstruction of blood flow and limited perfusion. Further complications include pulmonary embolism, thrombosis-induced myocardial infraction, ischemic stroke, and others. Location and full delineation of the blood clot are considered to be two clinically relevant aspects that could streamline proper diagnosis and treatment follow-up. In this work, we prepared two types of X-ray attenuating contrast formulations, using fibrinogen aptamer as the clot-seeking moiety. Methods: Two novel aptamer-targeted formulations were designed. Iodine-modified bases were directly incorporated into a fibrinogen aptamer (iodo-FA). Isothermal titration calorimetry was used to confirm that these modifications did not negatively impact target binding. Iodo-FA was tested for its ability to produce concentration-dependent contrast enhancement in a phantom CT. It was subsequently tested in vitro with clotted human and swine blood. This allowed for translation into ex vivo testing, using fluoroscopy. FA was also used to functionalize gold nanoparticles (FA-AuNPs), and contrast capabilities were confirmed. This formulation was tested in vitro using clotted human blood in a CT scan. Results: Unmodified FA and iodo-FA demonstrated a nearly identical affinity toward fibrin, confirming that base modifications did not impact target binding. Iodo-FA and FA-AuNPs both demonstrated excellent concentration-dependent contrast enhancement capabilities (40.5 HU mM-1 and 563.6 HU μM-1, respectively), which were superior to the clinically available agent, iopamidol. In vitro CT testing revealed that iodo-FA is able to penetrate into the blood clots, producing contrast enhancement throughout, while FA-AuNPs only accumulated on the surface of the clot. Iodo-FA was thereby translated to ex vivo testing, confirming target-binding associated accumulation of the contrast material at the location of the clot within the dilation of the external carotid artery. This resulted in a 34% enhancement of the clot. Conclusions: Both iodo-FA and FA-AuNPs were confirmed to be effective contrast formulations in CT. Targeting of fibrin, a major structural constituent of thrombi, with these novel contrast agents would allow for higher contrast enhancement and better clot delineation in CT and fluoroscopy.
- Published
- 2020
41. An In-Silico Pipeline for Rapid Screening of DNA Aptamers against Mycotoxins: The Case-Study of Fumonisin B1, Aflatoxin B1 and Ochratoxin A
- Author
-
Lucia Catucci, Fulvio Ciriaco, Michelangelo Pascale, Antonio F. Logrieco, Annalisa De Girolamo, Vincenzo De Leo, and Maria C. DeRosa
- Subjects
Ochratoxin A ,Polymers and Plastics ,In silico ,Aptamer ,01 natural sciences ,Article ,ssDNA aptamers ,lcsh:QD241-441 ,in-silico approach ,03 medical and health sciences ,chemistry.chemical_compound ,lcsh:Organic chemistry ,fumonisin B1 ,mycotoxins ,binding affinity ,030304 developmental biology ,0303 health sciences ,Fumonisin B1 ,Oligonucleotide ,Chemistry ,Microscale thermophoresis ,010401 analytical chemistry ,General Chemistry ,Small molecule ,0104 chemical sciences ,3. Good health ,Biochemistry ,aflatoxin B1 ,ochratoxin A ,Systematic evolution of ligands by exponential enrichment - Abstract
Aptamers are single-stranded oligonucleotides selected by SELEX (Systematic Evolution of Ligands by EXponential Enrichment) able to discriminate target molecules with high affinity and specificity, even in the case of very closely related structures. Aptamers have been produced for several targets including small molecules like mycotoxins, however, the high affinity for their respective target molecules is a critical requirement. In the last decade, the screening through computational methods of aptamers for their affinity against specific targets has greatly increased and is becoming a commonly used procedure due to its convenience and low costs. This paper describes an in-silico approach for rapid screening of ten ssDNA aptamer sequences against fumonisin B1 (FB1, n = 3), aflatoxin B1 (AFB1, n = 2) and ochratoxin A (OTA, n = 5). Theoretical results were compared with those obtained by testing the same aptamers by fluorescent microscale thermophoresis and by magnetic beads assay for their binding affinity (KD) revealing a good agreement.
- Published
- 2020
42. Optimized experimental pre-treatment strategy for temporary inhibition of islet amyloid polypeptide aggregation
- Author
-
Maria C. DeRosa and Madison Q. Ferguson
- Subjects
0301 basic medicine ,Tris ,endocrine system ,Islet amyloid polypeptide ,Amyloid ,QH301-705.5 ,Short Communication ,Biophysics ,chemistry.chemical_element ,Peptide ,QD415-436 ,Calcium ,Fibril ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Aggregation ,0302 clinical medicine ,Biology (General) ,chemistry.chemical_classification ,geography ,Thioflavin T assay ,geography.geographical_feature_category ,Type 2 diabetes ,Islet ,3. Good health ,Ammonium hydroxide ,030104 developmental biology ,Type 1 diabetes ,chemistry ,030220 oncology & carcinogenesis ,Thioflavin ,Transmission electron microscopy - Abstract
Islet amyloid polypeptide (IAPP) is a neuroendocrine hormone from pancreatic β-cells. Misfolded, aggregated IAPP is believed to be toxic to islet cells and amyloid deposits in the pancreas are pathological hallmarks of type 2 diabetes. Rapid fibrillization of this peptide makes it difficult to study in its soluble form, impeding a better understanding of its role. In this study, a variety of popular pretreatment methods were tested for their ability to delay aggregation of IAPP, including solutions of hexafluoroisopropanol, sodium hydroxide, hydrochloric acid, phosphate buffered saline, ammonium hydroxide, as well as tris buffer at different pH and containing either calcium (II), zinc (II), or iron (II). Aggregation was assessed using the thioflavin T fluorescence assay as well as by transmission electron microscopy. Tris buffer at pH 8.1 containing Zn(II) was found to have the best balance of temporary inhibition of aggregation and biological relevance., Graphical abstract Image 1
- Published
- 2020
43. HER2 biosensing through SPR-envelope tracking in plasmonic optical fiber gratings
- Author
-
Christophe Caucheteur, Ruddy Wattiez, Karima Chah, Maria C. DeRosa, Eman M. Hassan, Maxime Lobry, Médéric Loyez, and Erik Goormaghtigh
- Subjects
Optical fiber cable ,0303 health sciences ,Optical fiber ,Materials science ,business.industry ,Biochimie ,Sciences de l'ingénieur ,Cladding mode ,Biochemical detection ,01 natural sciences ,Atomic and Molecular Physics, and Optics ,Article ,law.invention ,010309 optics ,03 medical and health sciences ,Fiber Bragg grating ,law ,0103 physical sciences ,Demodulation ,Optoelectronics ,business ,Biosensor ,Plasmon ,030304 developmental biology ,Biotechnology - Abstract
In the biomedical detection context, plasmonic tilted fiber Bragg gratings (TFBGs) have been demonstrated to be a very accurate and sensitive sensing tool, especially well-adapted for biochemical detection. In this work, we have developed an aptasensor following a triple strategy to improve the overall sensing performances and robustness. Single polarization fiber (SPF) is used as biosensor substrate while the demodulation is based on tracking a peculiar feature of the lower envelope of the cladding mode resonances spectrum. This method is highly sensitive and yields wavelength shifts several tens of times higher than the ones reported so far based on the tracking of individual modes of the spectrum. An amplification of the response is further performed through a sandwich assay by the use of specific antibodies. These improvements have been achieved on a biosensor developed for the detection of the HER2 (Human Epidermal Growth Factor Receptor-2) protein, a relevant breast cancer biomarker. These advanced developments can be very interesting for point-of-care biomedical measurements in a convenient practical way.
- Published
- 2020
44. DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing
- Author
-
Andreas H. Farnleitner, Maria C. DeRosa, Claudia Kolm, Georg H. Reischer, Ulrich J Aschl, Robert L. Mach, Regina Sommer, Isabella Cervenka, Alexander K. T. Kirschner, Rudolf Krska, Stefan Jakwerth, and Niklas Baumann
- Subjects
0301 basic medicine ,Aptamer ,030106 microbiology ,DNA, Single-Stranded ,Computational biology ,Real-Time Polymerase Chain Reaction ,Article ,Enterococcus faecalis ,03 medical and health sciences ,chemistry.chemical_compound ,Selection (genetic algorithm) ,Multidisciplinary ,Bacteria ,biology ,SELEX Aptamer Technique ,High-Throughput Nucleotide Sequencing ,DNA ,Amplicon ,Aptamers, Nucleotide ,biology.organism_classification ,030104 developmental biology ,Real-time polymerase chain reaction ,chemistry ,Enterococcus ,Systematic evolution of ligands by exponential enrichment - Abstract
DNA aptamers generated by cell-SELEX against bacterial cells have gained increased interest as novel and cost-effective affinity reagents for cell labelling, imaging and biosensing. Here we describe the selection and identification of DNA aptamers for bacterial cells using a combined approach based on cell-SELEX, state-of-the-art applications of quantitative real-time PCR (qPCR), next-generation sequencing (NGS) and bioinformatic data analysis. This approach is demonstrated on Enterococcus faecalis (E. faecalis), which served as target in eleven rounds of cell-SELEX with multiple subtractive counter-selections against non-target species. During the selection, we applied qPCR-based analyses to evaluate the ssDNA pool size and remelting curve analysis of qPCR amplicons to monitor changes in pool diversity and sequence enrichment. Based on NGS-derived data, we identified 16 aptamer candidates. Among these, aptamer EF508 exhibited high binding affinity to E. faecalis cells (KD-value: 37 nM) and successfully discriminated E. faecalis from 20 different Enterococcus and non-Enterococcus spp. Our results demonstrate that this combined approach enabled the rapid and efficient identification of an aptamer with both high affinity and high specificity. Furthermore, the applied monitoring and assessment techniques provide insight into the selection process and can be highly useful to study and improve experimental cell-SELEX designs to increase selection efficiency.
- Published
- 2020
45. Highly sensitive magnetic-microparticle-based aptasensor for Cryptosporidium parvum oocyst detection in river water and wastewater: Effect of truncation on aptamer affinity
- Author
-
Maria C. DeRosa, Brent R. Dixon, Syed A. Sattar, Andrew Stalker, Eman M. Hassan, and Banu Örmeci
- Subjects
medicine.drug_class ,animal diseases ,Aptamer ,aptamers minimers ,Cryptosporidiosis ,Cryptosporidium ,02 engineering and technology ,Wastewater ,Monoclonal antibody ,01 natural sciences ,Analytical Chemistry ,chemistry.chemical_compound ,Rivers ,parasitic diseases ,Water environment ,medicine ,Animals ,Detection limit ,Cryptosporidium parvum ,limit of detection ,Chromatography ,biology ,Chemistry ,flow cytometry ,Magnetic Phenomena ,010401 analytical chemistry ,Oocysts ,Water ,021001 nanoscience & nanotechnology ,Ligand (biochemistry) ,biology.organism_classification ,6. Clean water ,0104 chemical sciences ,0210 nano-technology ,DNA - Abstract
Many methods have been reported to detect Cryptosporidium parvum (C. parvum) oocysts in the water environment using monoclonal antibodies. Herein, we report the use of DNA aptamers as an alternative ligand. We present the highly sensitive detection of C. parvum oocysts in wastewater samples based on aptamer-conjugated magnetic beads. A previously selected DNA aptamer (R4-6) that binds to C. parvum oocysts with high affinity and selectivity was rationally truncated into two minimer aptamers (Min_Crypto1 and Min_Crypto2), and conjugated to micro-magnetic beads. In flow cytometry tests with phosphate buffer, river water, and wastewater samples, both the minimers showed improved affinity and specificity toward C. parvum oocysts than the parent R4-6. Moreover, Min_Crypto2 showed higher affinity to its target than the parent aptamer when testing in wastewater, indicating superior binding properties in a complex matrix. Using a fluorescence microplate-based assay, and when incubated with different numbers of oocysts, Min_Crypto2 showed a limit of detection as low as 5 C. parvum oocysts in 300 μL of wastewater. Results described here indicate that Min_Crypto2 has superior specificity and sensitivity for the detection of C. parvum oocysts, and has a strong potential to be used successfully in a sensor.
- Published
- 2020
46. Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents
- Author
-
Maria C. DeRosa and Anna Koudrina
- Subjects
medicine.medical_specialty ,General Chemical Engineering ,Aptamer ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,medicine ,Medical imaging ,QD1-999 ,Targeting ligands ,medicine.diagnostic_test ,business.industry ,Disease progression ,Magnetic resonance imaging ,General Chemistry ,Mini-Review ,021001 nanoscience & nanotechnology ,Treatment efficacy ,0104 chemical sciences ,3. Good health ,Chemistry ,Radiology ,Molecular imaging ,0210 nano-technology ,business ,Target binding - Abstract
Computed tomography (CT) and magnetic resonance imaging (MRI) are among the most well-established modalities in the field of noninvasive medical imaging. Despite being powerful tools, both suffer from a number of limitations and often fall short when it comes to full delineation of pathological tissues. Since its conception, molecular imaging has been commonly utilized to further the understanding of disease progression, as well as monitor treatment efficacy. This has naturally led to the advancement of the field of targeted imaging. Targeted imaging research is currently dominated by ligand-modified contrast media for applications in MRI and CT imaging. Although a plethora of targeting ligands exist, a fine balance between their size and target binding efficiency must be considered. This review will focus on aptamer- and peptide-modified contrast agents, outlining selected formulations developed in recent years while highlighting the advantages offered by these targeting ligands.
- Published
- 2020
47. Circulating cancer cell detection using an optical fiber aptasensor
- Author
-
Ruddy Wattiez, Christophe Caucheteur, Maria C. DeRosa, Maxime Lobry, William G. Willmore, Médéric Loyez, Fu Liu, Jacques Albert, and Eman M. Hassan
- Subjects
Chemistry ,Biochimie ,Aptamer ,Cancer ,Sciences de l'ingénieur ,medicine.disease ,Metastasis ,Circulating tumor cell ,Colloidal gold ,Cancer cell ,medicine ,Cancer biomarkers ,Biosensor ,Biomedical engineering - Abstract
The detection of circulating tumor cells (CTCs) represents an important goal in oncological diagnosis and treatment, as CTCs are responsible for metastasis in several forms of cancer and are present at very low concentration. Their detection should occur at around 1-10 cells/mL of blood for diagnosis purpose. In this work, we propose an all-fiber plasmonic aptasensor featuring multiple narrowband resonances in the near-infrared wavelength range to detect metastatic breast cancer cells. To this aim, specific aptamers against mammaglobin-A proteins were selected and immobilized as bioreceptors on the optical fiber surface. In vitro assays confirm that label-free and real-time detection of cancer cells (LOD of 49 cells/mL) occurs within 5 minutes, while the additional use of functionalized gold nanoparticles allows a two-fold amplification of the biosensor response. Differential measurements on selected optical resonances were used to process the sensor response and results were confirmed by microscopy analysis. The detection of only 10 cancer cells/mL was performed with relevant specificity against non-target cells with comparable sizes and shapes.
- Published
- 2020
- Full Text
- View/download PDF
48. Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.
- Author
-
Cheng Cheng, LingShu Wang, Jason G. D. Gall, Martha Nason, Richard M. Schwartz, M. Juliana McElrath, Steven C. DeRosa, John Hural, Lawrence Corey, Susan P. Buchbinder, and Gary J. Nabel
- Subjects
Medicine ,Science - Published
- 2012
- Full Text
- View/download PDF
49. Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.
- Author
-
Cheng Cheng, Lingshu Wang, Jason G D Gall, Martha Nason, Richard M Schwartz, M Juliana McElrath, Steven C DeRosa, John Hural, Lawrence Corey, Susan P Buchbinder, and Gary J Nabel
- Subjects
Medicine ,Science - Abstract
The Step trial raised the possibility that uncircumcised men with pre-existing Ad5 neutralizing antibodies carried an increased risk of HIV infection after vaccination. Thus, understanding Ad seropositivity in humans is important to the development of an AIDS vaccine. Here, we analyze the impact of different Ad5-specific neutralizing antibodies on immune function and clinical outcome.Ad seropositivity in the Step trial volunteers was analyzed using chimeric rAd5/35 vectors to characterize their specificity for Ad5 fiber and non-fiber external (capsid) proteins. Immune responses and HIV seropositivity were correlated with the specificity of Ad5-neutralizing antibodies. Neutralizing antibodies induced by the vaccine in Ad5 seronegative subjects were directed preferentially to Ad5 capsid proteins, although some fiber-neutralizing antibodies could be detected. Pre-vaccination Ad5 serostatus did not affect the capsid-directed response after three vaccinations. In contrast, anti-fiber antibody titers were significantly higher in volunteers who were Ad5 seropositive prior to vaccination. Those Ad5 seropositive subjects who generated anti-capsid responses showed a marked reduction in vaccine-induced CD8 responses. Unexpectedly, anti-vector immunity differed qualitatively in Ad5 seropositive participants who became HIV-1 infected compared to uninfected case controls; Ad5 seropositive participants who later acquired HIV had lower neutralizing antibodies to capsid. Moreover, Ad35 seropositivity was decreased in HIV-infected subjects compared with uninfected case controls, while seroprevalence for other serotypes including Ad14, Ad28 and Ad41 was similar in both groups.Together, these findings suggest that the case subjects were less immunologically responsive prior to infection. Subjects infected during the Step trial had qualitative differences in immunity that increased their risk of HIV-1 infection independent of vaccination.
- Published
- 2012
- Full Text
- View/download PDF
50. Label-free aptasensors based on fluorescent screening assays for the detection of Salmonella typhimurium
- Author
-
Sathya Srinivasan, Maria C. DeRosa, Bhaskar Mohan Murari, and Velu Ranganathan
- Subjects
Salmonella typhimurium ,Salmonella ,Aptamer ,Biophysics ,Biosensing Techniques ,02 engineering and technology ,medicine.disease_cause ,01 natural sciences ,7. Clean energy ,Biochemistry ,Fluorescence ,chemistry.chemical_compound ,Fluorescence Resonance Energy Transfer ,Rhodamine B ,medicine ,Molecular Biology ,Detection limit ,Optical Imaging ,010401 analytical chemistry ,Cell Biology ,Aptamers, Nucleotide ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,Förster resonance energy transfer ,chemistry ,Colloidal gold ,SYBR Green I ,0210 nano-technology - Abstract
We report two label-free fluorescent aptasensor methods for the detection of S. typhimurium. In the first method, we have used a ‘‘turn off’’ approach in which the aptamer is first intercalated with SYBR Green I (SG), leading to a greatly enhanced fluorescence signal. The addition of S. typhimurium (approximately 1530–96938 CFU/mL), which specifically binds with its aptamer and releases SG, leads to a linear decrease in fluorescence intensity. The lowest detection limit achieved with this approach was in the range of 733 CFU/mL. In the second method, a ‘‘turn on’’ approach was designed for S. typhimurium through the Forster resonance energy transfer (FRET) between Rhodamine B (RB) and gold nanoparticles (AuNPs). When the aptamer and AuNPs were mixed with RB, the fluorescence of RB was significantly quenched via FRET. The aptamer adsorbs to the AuNP surface to protect them from salt-induced aggregation, which leads to the fluorescence quenching of RB in presence of AuNPs. Upon the addition of S. typhimurium, S. typhimurium specifically binds with its aptamer and loses the capability to stabilize AuNPs. Thus, the salt easily induces the aggregation of AuNPs, resulting in the fluorescence recovery of the quenched RB. S. typhimurium concentrations ranging from 1530 to 96938 CFU/mL with the detection limit of 464 CFU/mL was achieved with this methodology. Given these data, some insights into the molecular interactions between the aptamer and the bacterial target are provided. These aptasensor methods also may be adapted for the detection of a wide variety of targets.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.